Genomic & Biopharma News

Study finds worse survival rates for heart failure despite advances in treatment
A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.
News Medical Life Sciences, 2017-05-04 09:59:08

Findings reveal substantial burden of symptomatic hand osteoarthritis
A new study estimates that the lifetime risk of symptomatic hand osteoarthritis is 40%, and nearly one in two women and one in four men will develop the condition, which affects hand strength and function and causes disability in activities of daily living.
News Medical Life Sciences, 2017-05-04 09:53:58

Discovery could help design better drugs to fight against antibiotic-resistant superbugs
Antibiotic resistance is a growing global health threat. So much so that a 2014 study commissioned by the Prime Minister of the United Kingdom predicted that, if the problem is left unchecked, in less than 35 years more people will die from antibiotic-resistant superbugs than from cancer.
News Medical Life Sciences, 2017-05-04 09:50:35

AZ and Pieris link in $2.1bn respiratory deal
AstraZeneca has hooked up with US group Pieris Pharmaceuticals to develop novel inhaled medicines for respiratory diseases in a deal potentially worth $2.1 billion.
PharmaTimes, 2017-05-04 09:46:40

Novartis scoops up rights to NASH drug
Novartis has exercised an option giving it global development and commercialisation rights to an experimental drug being developed by US biotech Conatus for nonalcoholic steatohepatitis (NASH), a progressive form of non-alcoholic fatty liver disease.
PharmaTimes, 2017-05-04 09:42:21

£50 blood test could predict prostate cancer drug response
Researchers have developed a blood test that could better tailor the treatment of patients with prostate cancer.
PharmaTimes, 2017-05-04 09:39:13

Swiss majors Roche and Novartis back gene therapy upstart
Swiss majors Roche and Novartis back gene therapy upstart badams Thu, 05/04/2017 - 05:23
Fierce Biotech, 2017-05-04 09:23:28

George Clinical buys up CRO unit from Vector Oncology, boosting its operations
George Clinical buys up CRO unit from Vector Oncology, boosting its operations badams Thu, 05/04/2017 - 04:16
Fierce Biotech, 2017-05-04 08:16:45

Steroids offer no additional relief to emergency patients suffering from hives
Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, placebo-controlled, double-blind, parallel-group study published online yesterday in Annals of Emergency Medicine.
News Medical Life Sciences, 2017-05-04 08:14:00